| Terminated | 1 | 19 | US | TH-302, Nab-paclitaxel, Gemcitabine | Threshold Pharmaceuticals | Pancreatic Cancer | 09/15 | 05/16 | | |
NCT02598687: Testing TH-302, in Combination With Preoperative Chemoradiotherapy, in Esophageal Cancer. |
|
|
| Withdrawn | 1 | 0 | Europe | TH-302, HX4 scan, Carboplatin, Paclitaxel, Radiotherapy, surgery | Maastricht Radiation Oncology, Threshold Pharmaceuticals, Zuyderland Medical Centre | Esophageal Cancer | 04/16 | 04/16 | | |
